ARCHIVES

Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts

This article is from The Cancer Letter archive.

Vol. 01 No. 42 | November 23, 1974

Download PDF Visit The Full Archive

Related Articles

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

DCE Board Approves Recompetition Concepts

March 18, 1988

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014